These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1545171)

  • 1. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
    Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
    Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H; Schwörer D; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T; Mochizuki M; Nishimura R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The monitoring of gynecological radiotherapy using serial tumor marker determinations].
    Wagner RK; Atzinger A; Breit A
    Strahlenther Onkol; 1990 Jul; 166(7):446-52. PubMed ID: 2200151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary hCG beta-core fragment as a tumor marker for bladder cancer].
    Yamanaka N; Kawabata G; Morisue K; Hazama M; Nishimura R
    Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):700-6. PubMed ID: 8492514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
    Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
    Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
    Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
    Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
    Rinne K; Shahabi S; Cole L
    Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the levels of CA125, CA19-9, and CEA in the cervical mucus helps a diagnosis of cervical adenocarcinomas].
    Fujii S; Konishi I; Nanbu Y; Sagawa N; Nonogaki H; Mori T
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2193-4. PubMed ID: 3480920
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA; Tanaka A; Kim GS; Park SY; Koh MW; Schwartz PE; Chambers JT; Nam JH
    Gynecol Oncol; 1996 Feb; 60(2):264-70. PubMed ID: 8631549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-core fragment of human chorionic gonadotropin in cervical intraepithelial neoplasia (CIN).
    Norman RJ; de Medeiros S; Amato F; Davis G; Davy M
    Gynecol Oncol; 1993 Apr; 49(1):16-8. PubMed ID: 8482553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.